{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T05:30:06Z","timestamp":1700199006946},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1984,12,1]],"date-time":"1984-12-01T00:00:00Z","timestamp":470707200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmacokinetics and Biopharmaceutics"],"published-print":{"date-parts":[[1984,12]]},"DOI":"10.1007\/bf01059555","type":"journal-article","created":{"date-parts":[[2005,1,29]],"date-time":"2005-01-29T17:49:02Z","timestamp":1107020942000},"page":"597-610","source":"Crossref","is-referenced-by-count":9,"title":["Concentration andpH dependent steady-state volume of distribution of methotrexate estimated by a simple physiologically based method"],"prefix":"10.1007","volume":"12","author":[{"given":"Chung Y.","family":"Lui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myung G.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Win L.","family":"Chiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[1984,12,1]]},"reference":[{"key":"BF01059555_CR1","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1056\/NEJM198311033091805","volume":"309","author":"J. Jolivet","year":"1983","unstructured":"J. Jolivet, K. H. Cowan, G. A. Curt, N. J. Clendeninn, and B. A. Chabner. The pharmacology and clinical use of methotrexate.N. Engl. J. Med. 309:1094\u20131104 (1983).","journal-title":"N. Engl. J. Med."},{"key":"BF01059555_CR2","first-page":"573","volume":"40","author":"D. A. Gewirtz","year":"1980","unstructured":"D. A. Gewirtz, J. C. White, J. K. Randolph, and I. D. Goldman. Transport, binding, and polyglutamation of methotrexate in freshly isolated rat hepatocytes.Cancer Res. 40:573\u2013578 (1980).","journal-title":"Cancer Res."},{"key":"BF01059555_CR3","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/0006-2952(81)90378-6","volume":"30","author":"R. L. Schilsky","year":"1981","unstructured":"R. L. Schilsky, B. D. Bailey, and B. A. Chabner. Characteristics of membrane transport of methotrexate by cultured human breast cancer cells.Biochem. Pharmacol. 30:1537\u20131542 (1981).","journal-title":"Biochem. Pharmacol."},{"key":"BF01059555_CR4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1128\/JB.93.1.309-314.1967","volume":"93","author":"F. M. Sirotnak","year":"1967","unstructured":"F. M. Sirotnak, M. G. Sargent, and D. J. Hutchison. Genetically alterable transport of amethopterin in Diplococcus pneumoniae I. Physiological properties and kinetics of the wild-type system.J. Bacteriol. 93:309\u2013314 (1967).","journal-title":"J. Bacteriol."},{"key":"BF01059555_CR5","first-page":"75","volume":"28","author":"F. M. Sirotnak","year":"1968","unstructured":"F. M. Sirotnak, S. Kurita, and D. J. Hutchison. On the nature of a transport alteration determining resistance to amethopterin in the L1210 leukemia.Cancer Res. 28:75\u201380 (1968).","journal-title":"Cancer Res."},{"key":"BF01059555_CR6","first-page":"640","volume":"230","author":"W. B. Strum","year":"1977","unstructured":"W. B. Strum. ApH-dependent, carrier-mediated transport system for the folate analog, amethopterin, in rat jejunum.J. Pharmacol. Exp. Ther. 230:640\u2013645 (1977).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF01059555_CR7","first-page":"19","volume":"6","author":"R. G. Stoller","year":"1975","unstructured":"R. G. Stoller, S. A. Jacobs, J. C. Drake, R. J. Lutz, and B. A. Chabner. Pharmacokinetics of high-dose methotrexate (NSC-740).Cancer Chemother. Rep. 6:19\u201324 (1975).","journal-title":"Cancer Chemother. Rep."},{"key":"BF01059555_CR8","first-page":"1733","volume":"66","author":"H. Breithaupt","year":"1982","unstructured":"H. Breithaupt and E. Kuenzlen. Pharmacokinetics of methotrexate and 7-hydroxymethotrexate following infusions of high-dose methotrexate.Cancer Treat. Rep. 66:1733\u20131741 (1982).","journal-title":"Cancer Treat. Rep."},{"key":"BF01059555_CR9","first-page":"868","volume-title":"The Pharmacological Basis of Therapeutics","author":"G. H. Mudge","year":"1980","unstructured":"G. H. Mudge. Agents affecting volume and composition of body fluids. In A. G. Gilman, L. S. Goodman, and A. Gilman (eds.),The Pharmacological Basis of Therapeutics, 6th ed. Macmillan, New York, 1980, p. 868.","edition":"6th ed."},{"key":"BF01059555_CR10","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/jps.2600700841","volume":"70","author":"W. L. Chiou","year":"1981","unstructured":"W. L. Chiou and G. Lam. Simplified physiologically based method to estimate steady-state volume of distribution.J. Pharm. Sci. 70:967\u2013968 (1981).","journal-title":"J. Pharm. Sci."},{"key":"BF01059555_CR11","unstructured":"C. Y. Lui, M. G. Lee, and W. L. Chiou. UrinarypH and urine flow independent renal clearance of methotrexate in dogs, to be published."},{"key":"BF01059555_CR12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/bdd.2510020110","volume":"2","author":"M. G. Lee","year":"1981","unstructured":"M. G. Lee, M. L. Chen, S. M. Huang, and W. L. Chiou. Pharmacokinetics of drugs in blood I: Unusual distribution of gentamicin.Biopharm. Drug Dispos. 2:89\u201397 (1981).","journal-title":"Biopharm. Drug Dispos."},{"key":"BF01059555_CR13","first-page":"530","volume":"22","author":"M. G. Lee","year":"1984","unstructured":"M. G. Lee, C. Y. Lui, M. L. Chen, and W. L. Chiou. Pharmacokinetics in blood IV: Unusual distribution, storage effect and metabolism of methotrexate.Int. J. Clin. Pharmacol. Ther. Toxicol 22:530\u2013537 (1984).","journal-title":"Int. J. Clin. Pharmacol. Ther. Toxicol"},{"key":"BF01059555_CR14","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/BF01062209","volume":"11","author":"M. L. Chen","year":"1983","unstructured":"M. L. Chen and W. L. Chiou. Clearance studies of methotrexate and 7-hydroxymethotrexate in rabbits after multiple-dose infusion.J. Pharmacokin. Biopharm. 11:515\u2013520 (1983).","journal-title":"J. Pharmacokin. Biopharm."},{"key":"BF01059555_CR15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0378-4347(00)84213-9","volume":"226","author":"M. L. Chen","year":"1981","unstructured":"M. L. Chen and W. L. Chiou. Sensitive and rapid high-performance liquid chromatographic method for the simultaneous determination of methotrexate and its metabolites in plasma, saliva and urine.J. chromatogr. Biomed. Appl. 226:125\u2013134 (1981).","journal-title":"J. chromatogr. Biomed. Appl."},{"key":"BF01059555_CR16","first-page":"475","volume":"35","author":"A. Higashi","year":"1950","unstructured":"A. Higashi and L. Peters. A rapid colorimetric method for the determination of inulin in plasma and urine.J. Lab. Clin. Med. 35:475\u2013482 (1950).","journal-title":"J. Lab. Clin. Med."},{"key":"BF01059555_CR17","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/jps.2600711219","volume":"71","author":"M. L. Chen","year":"1982","unstructured":"M. L. Chen, G. Lam, M. G. Lee, and W. L. Chiou. Arterial and venous blood sampling in pharmacokinetic studies: griseofulvin.J. Pharm. Sci. 71:1386\u20131389 (1982).","journal-title":"J. Pharm. Sci."},{"key":"BF01059555_CR18","first-page":"1008","volume":"25","author":"E. S. Henderson","year":"1965","unstructured":"E. S. Henderson, R. H. Adamson, C. Denham, and V. T. Oliverio. The metabolic fate of tritiated methotrexate I. Absorption, excretion and distribution in mice, rats, dogs and monkeys.Cancer Res. 25:1008\u20131017 (1965).","journal-title":"Cancer Res."},{"key":"BF01059555_CR19","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1172\/JCI104391","volume":"40","author":"D. G. Johns","year":"1961","unstructured":"D. G. Johns, S. Sperti, and S. V. Burgen. The metabolism of tritiated folic acid in man.J. Clin. Invest. 40:1684\u20131695 (1961).","journal-title":"J. Clin. Invest."},{"key":"BF01059555_CR20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.2042-7158.1983.tb04282.x","volume":"35","author":"G. M. Rubin","year":"1983","unstructured":"G. M. Rubin, T. N. Tozer, and S. \u00d8ie. Concentration-dependence of salicylate distribution.J. Pharm. Pharmacol. 35:115\u2013117 (1983).","journal-title":"J. Pharm. Pharmacol."},{"key":"BF01059555_CR21","first-page":"345","volume":"92","author":"J. W. Jailer","year":"1948","unstructured":"J. W. Jailer, C. G. Zubrod, M. Rosenfield, and J. A. Shannon. Effect of acidosis and anoxia on the concentration of quinacrine and chloroquine in blood.J. Pharmacol. Exp. Ther. 92:345\u2013351 (1948).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF01059555_CR22","first-page":"85","volume":"98","author":"B. B. Brodie","year":"1950","unstructured":"B. B. Brodie, L. C. Mark, E. M. Papper, P. A. Life, E. Bernstein, and E. A. Rovenstine. The fate of thiopental in man and a method for its estimation in biological material.J. Pharmacol. Exp. Ther. 98:85\u201396 (1950).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF01059555_CR23","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1172\/JCI103518","volume":"36","author":"W. J. Waddell","year":"1957","unstructured":"W. J. Waddell and T. C. Butler. The distribution and excretion of phenobarbital.J. Clin. Invest. 36:1217\u20131226 (1957).","journal-title":"J. Clin. Invest."},{"key":"BF01059555_CR24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/BF01062208","volume":"11","author":"M. L. Chen","year":"1983","unstructured":"M. L. Chen and W. L. Chiou. Pharmacokinetics of methotrexate and 7-hydroxymethotrexate in rabbits after i.v. administration.J. Pharmacokin. Biopharm. 11:499\u2013513 (1983).","journal-title":"J. Pharmacokin. Biopharm."},{"key":"BF01059555_CR25","first-page":"1","volume":"22","author":"M. L. Chen","year":"1984","unstructured":"M. L. Chen, W. P. McQuire, T. E. Lad, and W. L. Chiou. A specific HPLC assay to determine the pharmacokinetics of methotrexate in patients.Int. J. Clin. Pharmacol Ther. Toxicol. 22:1\u20136 (1984).","journal-title":"Int. J. Clin. Pharmacol Ther. Toxicol."},{"key":"BF01059555_CR26","first-page":"381","volume":"19","author":"A. J. Patterson","year":"1981","unstructured":"A. J. Patterson, W. A. Ritschel, D. Zellner, and S. H. Kim. Methotrexate serum and saliva concentrations in patients.Int. J. Clin. Pharmacol. Ther. Toxicol. 19:381\u2013385 (1981).","journal-title":"Int. J. Clin. Pharmacol. Ther. Toxicol."},{"key":"BF01059555_CR27","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/BF00562319","volume":"8","author":"L. Kristensen","year":"1975","unstructured":"L. Kristensen, K. Weismann, and L. Hutters. Renal function and the rate of disappearance of methotrexate from serum.Eur. J. Clin. Pharmacol. 8:439\u2013444 (1975).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"BF01059555_CR28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF00607446","volume":"14","author":"D. Bratlid","year":"1978","unstructured":"D. Bratlid and P. J. Moe. Pharmacokinetics of high-dose methotrexate treatment in children.Eur. J. Clin. Pharmacol. 14:143\u2013147 (1978).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"BF01059555_CR29","first-page":"482","volume":"16","author":"C. F. Stewart","year":"1982","unstructured":"C. F. Stewart, W. R. Crom, W. P. Bowman, P. R. Hutson, and W. E. Evans. Influence of serum concentration on renal clearance of methotrexate in children with acute lymphocytic leukemia.Drug Intell. Clin. Pharm. 16:482 (1982).","journal-title":"Drug Intell. Clin. Pharm."},{"key":"BF01059555_CR30","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/j.1552-4604.1983.tb02753.x","volume":"23","author":"D. J. Greenblatt","year":"1983","unstructured":"D. J. Greenblatt, D. R. Abernethy, and M. Divoll. Is volume of distribution at steady state a meaningful kinetic variable?J. Clin. Pharmacol. 23:391\u2013400 (1983).","journal-title":"J. Clin. Pharmacol."},{"key":"BF01059555_CR31","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/jps.2600700129","volume":"70","author":"W. L. Chiou","year":"1981","unstructured":"W. L. Chiou, C. Y. Lui, and G. Lam. Plasma area method in relative bioavailability evaluation of drugs with changing biological half-lives.J. Pharm. Sci. 70:109\u2013112 (1981).","journal-title":"J. Pharm. Sci."},{"key":"BF01059555_CR32","first-page":"499","volume":"33","author":"W. L. Chiou","year":"1981","unstructured":"W. L. Chiou. The physiological significance of the apparent volume of distribution, Vd\u03b2 or Vdarea, in pharmacokinetic studies.Res. Commun. Chem. Pathol. Pharmacol. 33:499\u2013508 (1981).","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"BF01059555_CR33","first-page":"4843","volume":"39","author":"K. C. Huang","year":"1979","unstructured":"K. C. Huang, B. A. Wenczak, and Y. K. Liu. Renal tubular transport of methotrexate in the rhesus monkey and dog.Cancer Res. 39:4843\u20134848 (1979).","journal-title":"Cancer Res."},{"key":"BF01059555_CR34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/1097-0142(197801)41:1<36::AID-CNCR2820410108>3.0.CO;2-I","volume":"41","author":"W. A. Bleyer","year":"1978","unstructured":"W. A. Bleyer. The clinical pharmacology of methotrexate.Cancer 41:36\u201351 (1978).","journal-title":"Cancer"},{"key":"BF01059555_CR35","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.2042-7158.1982.tb04206.x","volume":"34","author":"G. Lam","year":"1981","unstructured":"G. Lam and W. L. Chiou. Determination of the steady-state volume of distribution using arterial and venous plasma data from constant infusion studies with procainamide.J. Pharm. Pharmacol. 34:132\u2013134 (1981).","journal-title":"J. Pharm. Pharmacol."},{"key":"BF01059555_CR36","first-page":"17","volume":"35","author":"W. L. Chiou","year":"1982","unstructured":"W. L. Chiou, G. Lam, M. L. Chen, and M. G. Lee. Effect of arterial-venous plasma concentration difference on the determination of mean residence time of drugs in the body.Res. Commun. Chem. Pathol. Pharmacol. 35:17\u201326 (1982).","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."}],"container-title":["Journal of Pharmacokinetics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01059555.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01059555\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01059555","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T13:46:59Z","timestamp":1586094419000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01059555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,12]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1984,12]]}},"alternative-id":["BF01059555"],"URL":"https:\/\/doi.org\/10.1007\/bf01059555","relation":{},"ISSN":["0090-466X"],"issn-type":[{"value":"0090-466X","type":"print"}],"subject":[],"published":{"date-parts":[[1984,12]]}}}